Acute Otitis Externa (External Ear Canal Inflammation or Swimmer's Ear)

Overview

Acute otitis externa is diffuse infectious inflammation of the external ear canal and, by definition, lasts less than 6 weeks; a course longer than 3 months or frequent recurrence is categorized separately as chronic otitis externa. Pathogenesis begins with disruption of the canal's protective cerumen-acid barrier.

Warm humid conditions, swimming, mechanical trauma from cotton swabs or earphones and earplug use damage this barrier and permit bacterial invasion. The main organisms are Pseudomonas aeruginosa and Staphylococcus aureus; anaerobes may contribute in mixed bacterial flora, while Aspergillus and Candida species cause otomycosis.

Patients usually present within hours to days with rapidly progressive ear pain, itching, fullness and serous or purulent discharge; pain is often disproportionately severe. Pain that markedly increases with tragal pressure or pulling the auricle is characteristic of AOE and is the most reliable clinical finding.

Examination shows canal erythema, edema, debris and discharge; with advanced edema the canal may close completely and the tympanic membrane may not be visible. Diagnosis is primarily clinical and routine culture is unnecessary.

Obtain culture only in treatment-resistant disease or when immunosuppression or necrotizing disease is suspected. Treatment is canal cleaning by suction or irrigation plus topical antimicrobial with or without corticosteroid drops.

Topical treatment provides a local concentration that cannot be achieved in infected tissue with systemic dosing and nearly eliminates systemic adverse-effect risk, so it is first-line. In older, uncontrolled diabetic or immunosuppressed patients, the same initial findings may hide necrotizing (malignant) otitis externa, which has a completely different course and treatment duration from uncomplicated AOE.

Acute otitis externa is common: in the United States, approximately one in every 123 people develops it each year, with a marked increase in summer, warm humid climates and swimmers. The epidemiology of necrotizing otitis externa is changing; an English hospital-record analysis covering 2002-2024 showed a continuing increase in national incidence, strongly associated with an aging population and increasing diabetes prevalence.

Necrotizing disease should therefore be treated as an increasingly encountered clinical scenario rather than only a rare exception.

Key considerations

• Necrotizing (malignant) otitis externa is spread from the external canal through the bone-cartilage junction to the skull base in an older, especially uncontrolled diabetic or immunosuppressed patient. Severe nocturnal pain, granulation tissue at the canal floor and later cranial-nerve involvement are typical; manage it with a separate urgent protocol.
• Acute otitis media causes middle-ear pain and discharge, with or without tympanic-membrane perforation. Increased pain with tragal pressure favors AOE, while direct assessment of the tympanic membrane on otoscopy supports the distinction.
• Otomycosis should be considered in prolonged or antibacterial-treatment-resistant disease; itching is more prominent than in bacterial disease and the canal may contain wet newspaper-like debris, fungal hyphae or black-white spore clusters.
• Herpes zoster oticus (Ramsay Hunt syndrome) causes painful vesicular rash on the auricle and external canal, usually with ipsilateral facial paralysis and sometimes hearing loss or vertigo; this triad is not expected in AOE.
• Contact or eczematous dermatitis presents with itchy, scaly and usually non-draining disease after exposure to ear drops, shampoo or earrings; tragal tenderness is less prominent than in AOE.
• Cerumen impaction causes fullness and reduced hearing without infection findings; a compact cerumen mass is seen instead of canal erythema and discharge.
• A foreign body in the external canal, especially in children, can cause unilateral pain, discharge and foul odor; otoscopy makes the diagnosis directly.
• A furuncle, or localized bacterial folliculitis, causes a focal fluctuant swelling and severe pain in one canal region rather than diffuse canal involvement and may require incision and drainage.
• Mastoiditis presents with mastoid tenderness, erythema and forward displacement of the pinna and usually follows untreated middle-ear infection; confirm with imaging when needed.
• Chronic otitis externa is considered when symptoms last longer than 3 months or recur frequently; itching dominates, pain is milder than in the acute form and underlying allergic dermatitis, chronic moisture exposure or canal-anatomy abnormality should be investigated.

Why it matters

The AAO-HNS 2014 acute otitis externa guideline (Rosenfeld et al.) recommends a topical agent as initial treatment for uncomplicated diffuse AOE and does not recommend routine systemic antibiotics. This is based on three meta-analyses showing no clinical outcome difference between quinolone and non-quinolone agents; agent choice is therefore driven largely by ototoxicity profile and cost.

The guideline's recommendation for a non-ototoxic, aminoglycoside-free drop when the tympanic membrane is perforated or a tube is present is extrapolated from animal data rather than direct human evidence and is graded as moderate confidence by the guideline. It reflects precaution despite ototoxicity being rarely observed clinically.

Suspected necrotizing otitis externa is fundamentally different: according to the StatPearls review, it is skull-base osteomyelitis that can involve the facial, glossopharyngeal, vagus and hypoglossal nerves, requires systemic usually antipseudomonal fluoroquinolone-based antimicrobial therapy for weeks to months and is followed with clinical response and inflammatory markers, especially ESR. Do not confuse this with a 7-day topical model for uncomplicated AOE.

Imaging evidence also varies. A systematic review and meta-analysis found CT sensitivity approximately 71% when bone erosion alone was assessed and 96% when bone erosion and soft-tissue findings were combined; MRI sensitivity was approximately 94%, technetium-99m bone scintigraphy 97% and gallium-67 scintigraphy 94%.

The same meta-analysis emphasized that specificity could not be assessed in any study because the disease is rare, so imaging alone does not establish the diagnosis and must be interpreted with clinical findings. The former habit of adding routine systemic antibiotics to simple AOE as a safety margin has been abandoned because topical therapy achieves higher local concentration and unnecessary systemic antibiotics increase resistance and adverse effects.

A 2010 Cochrane systematic review of 19 randomized controlled trials involving 3382 participants found no meaningful clinical-improvement difference between topical classes (quinolone, aminoglycoside, single agent or corticosteroid combination), but a corticosteroid-containing topical antimicrobial was clearly superior to placebo drops in one study (odds ratio 11). This supports selecting an agent by cost, tympanic-membrane integrity and adherence rather than presumed efficacy.

The AAFP 2023 rapid evidence review confirmed no meaningful outcome difference between quinolone and non-quinolone antibiotics or between corticosteroid-containing and non-corticosteroid preparations; reconsider treatment when there is no response after 48-72 hours.

Critical complications

• Canal stenosis develops when recurrent or chronic inflammation causes fibrosis; progressive hearing loss and persistent fullness reveal it and advanced disease may require canaloplasty.
• Necrotizing (malignant) otitis externa occurs when untreated or late-diagnosed AOE progresses to skull-base osteomyelitis in a patient with risk factors; worsening nocturnal pain is typical and prolonged systemic antipseudomonal treatment with close ENT follow-up is required.
• Facial-nerve palsy is the most common cranial-nerve complication of necrotizing otitis externa and has been reported in approximately 21% of cases; without early diagnosis and aggressive systemic treatment, permanent deficit may result.
• Extension to the abducens or trigeminal nerve is a poor prognostic sign and requires urgent advanced imaging and more intensive treatment.
• Meningitis, dural venous-sinus thrombosis and brain abscess are serious intracranial complications of skull-base spread and present with acute neurologic deterioration or altered consciousness; obtain urgent neurosurgical and infectious-disease consultation.
• Contact dermatitis and allergic sensitization, especially after prolonged use of neomycin-containing preparations, present with worsening itching and erythema during treatment and require a change of agent.
• Ototoxicity can cause hearing loss or imbalance when aminoglycoside drops reach the inner ear through a tympanic-membrane perforation or tube; prevent it by choosing a non-ototoxic preparation.
• Current series report 10-20% mortality in necrotizing otitis externa, down from historical rates of 50-60% with early diagnosis, imaging and prolonged antipseudomonal treatment. Recurrence can occur in 15-20% within one year after treatment, requiring long-term follow-up.

Special considerations

• In pregnancy, topical ciprofloxacin or dexamethasone combination can be used as first-line therapy because systemic absorption is negligible; if systemic antibiotics are rarely required, avoid contraindicated agents such as systemic fluoroquinolones and select a pregnancy-appropriate alternative.
• Diagnosis and topical management in children resemble adults, but the canal is narrower and wick placement may be technically difficult; teach parents how to administer drops. Because tympanostomy tubes are common in children, specifically verify the choice of a non-ototoxic preparation.
• In an older patient, especially with diabetes, distinguishing simple AOE from necrotizing disease can be difficult; severe or nocturnal pain out of proportion or granulation tissue should prompt a low-threshold assessment for necrotizing disease.
• Uncontrolled diabetes increases both the risk and severity of necrotizing otitis externa through small-vessel vasculopathy and impaired immune response; tight glycemic control is an integral part of treatment and a reason not to rely on topical therapy alone.
• Immunosuppression from HIV infection, malignancy or chemotherapy is an independent risk factor for necrotizing otitis externa; even an apparently simple AOE warrants a lower threshold for advanced imaging and ENT consultation.
• Necrotizing otitis externa with cranial-nerve involvement or extension to the abducens or trigeminal nerve has worse prognosis because it indicates more advanced skull-base spread; intensify treatment accordingly.
• There is no direct evidence that obesity alone changes AOE risk or course, but associated diabetes and altered canal anatomy may complicate assessment; check glycemic status.

Follow-up plan

In uncomplicated diffuse AOE, clear symptomatic improvement is expected within 48-72 hours after topical treatment. If there is no improvement, reassess for otomycosis, tympanic-membrane perforation, foreign body, nonadherence, inadequate drop delivery through an edematous canal requiring a wick and necrotizing disease.

Keep the canal dry, avoid swimming and water exposure during treatment, reduce earplug use and do not clean the canal with cotton swabs; these measures speed healing and reduce recurrence. Monitor response more closely and schedule earlier review in diabetes or immunosuppression.

Tell the patient to return urgently for worsening or nocturnal pain, fever, facial weakness, hearing loss, dizziness or vertigo or periauricular swelling because these can be early signs of necrotizing disease or spread beyond the canal. In confirmed necrotizing otitis externa, follow treatment response with pain scores and inflammatory markers such as ESR; treatment usually lasts weeks, and because recurrence is approximately 15-20%, arrange periodic follow-up for at least one year after treatment.

For recurrent simple AOE, plan preventive measures such as drying after swimming, acetic-acid prophylactic drops when appropriate and ENT assessment for canal anatomy. In swimmers or frequent recurrence, drying the canal after bathing with a hair dryer on its lowest setting held several centimeters away is practical and inexpensive; prophylactic acetic-acid and isopropyl-alcohol drops may be used immediately after water exposure.